Dedicated, diligent, and solution-oriented R&D professional with a team-first mentality, skilled in assay development, gene editing, ligand-binding assays, and phenotypic screening across biotech and academic settings. Contributed to IND-enabling programs through cross-functional partnerships and CRO collaborations, with therapeutic focus in fibrosis, oncology, diabetes, DMD, celiac disease, and Alzheimer's. Skilled in assay scalability, automation integration, mentoring, and presenting complex data to accelerate therapeutic development. Author and co-author of peer-reviewed research and presenter at state-level conferences.